Iastrebner, Marcelo, Joaquín Castro, Edgardo García Espina, Carolina Lettieri, Silvio Payaslian, María Celia Cuesta, Pablo Gutiérrez Fernández, Araceli Mandrile, Angela Paola Contreras, Sebastián Gervasoni, Gabriel Verde, Cayetano Galetti, Estefanía Minoldo, and Vanesa Caruso. 2021. “Ruxolitinib in Severe COVID-19: Results of a Multicenter, Prospective, Single Arm, Open-Label Clinical Study to Investigate the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 and Severe Acute Respiratory Syndrome”. Revista De La Facultad De Ciencias Médicas De Córdoba. 78 (3):294-302. https://doi.org/10.31053/1853.0605.v78.n3.32800.